ADHD is a neurodevelopmental condition that affects both children and adults. It is characterised by symptoms such as ...

Granules Pharmaceuticals, a wholly-owned subsidiary of Granules India, has received tentative approval from the US Food and ...

Aizhida is a central nervous system stimulant indicated for the treatment of ADHD. Each once-daily capsule contains serdexmethylphenidate (SDX), a prodrug of dexmethylphenidate, c ...

In response to the ongoing shortage of ADHD medications, the U.S. Food and Drug Administration (FDA) has approved several generic versions of Vyvanse ...

Granules India received tentative USFDA approval for Amphetamine Extended-Release Orally Disintegrating Tablets, offering 180 ...

Granules said on December 22, 2025 it had received a tentative approval for the Amphetamine Extended-Release Orally ...

If you have attention deficit hyperactivity disorder (ADHD), you may have had a hard time getting your medications refilled because of drug shortages that date back to 2022—which are still ongoing, ...

Heading into back-to-school season, the ongoing shortage of ADHD medications has sparked concern among some parents of children who have attention-deficit ...

Earlier this year, Clara Pitts got the news she was hoping for: She had been accepted to her dream school, Brigham Young University.It was a feat made all the more joyful for Clara and her family ...

(BPT) – Getting back into the swing of things for this year’s return to school may be a challenge after more than 18 months away, and even more so for children living with ADHD. But caregiver concerns ...

FILE - Adderall XR capsules are displayed on Feb. 24, 2023. Drug shortages are growing in the United States, and experts see no clear path to resolving them. The U.S. Food and Drug Administration ...